2
7
9
Chipscreen Biosciences focuses on two major areas, oncology and metabolism, while continuously addressing significant unmet clinical needs such as neurodegenerative diseases and autoimmune disorders. The company is strengthening the differentiated layout of its pipelines to consistently enhance benefits for global patients.